Hello and good morning to everyone, and welcome to Arjo's Q3 2025 Earnings Call.
With me here today, I have Christofer Carlsson, our CFO. We will provide some details on the quarter three report that we released an hour ago. The agenda looks as usual and includes a summary of activities and results from quarter three, the balance sheet items, and the outlook for 2025. Before we open up for questions, we intend to keep this call to an hour and finish no later than 9:00. Next slide please. We closed the third quarter in a solid manner and observed continued demand, with organic net sales growth aligning well with our targeted range. And as expected, it is sequentially higher than the first half of the year. We had continued strong momentum for our service business, now also supported by stronger growth in our capital sales, while our rental business was slower this quarter. Our North America business is showing stable growth this quarter, while global sales are now delivering from a strong order book and healthy customer demand, demonstrating the strongest growth quarter in several years. This altogether makes us close the quarter with a +3.8% organic net sales growth for the group. We continue to have a materially higher order book than the same period last year, and we are looking forward to a strong finish of the year in quarter four.
Our gross margin came in at 41.1% compared to last year's 42.0%. We continue to receive support from lower material costs and price adjustments. While these improvements are offset by currency and US tariff headwinds in quarter three. We also had an unfavorable geographic mix impact due to the relatively higher sales volume in global sales and the rest of the world markets, as well as higher medical bed sales, which also impact the gross margin. Excluding currency and US tariffs. The gross margin would have been on par with last year, despite the product mix effects.
For the rest of 2025, we will continue to drive efficiency focus throughout the value chain based on the plans that we have put in place.
For example, within the supply chain, our focus on price adjustments will obviously also remain to secure compensation for salary inflation and the US tariffs.
The organization is doing a good job on the OpEx side, and we have been able to slow down the cost increase compared to quarter two. Our efforts to increase cost efficiency are showing effects, bringing down the organic OpEx growth compared to last year, to almost flat. Adjusted EBITDA for the quarter increased to 436 million, compared to 434 million in quarter three last year, a result stemming from higher sales and an improved Opex to sales ratio. The adjusted EBITDA margin improved by 0.6 percentage points versus last year.
Overall, our underlying profitability continues to improve, and excluding the effects of currencies and tariffs, the adjusted operating profit increased by over 20%. Our operational cash flow came in at 446 million, leading to a cash conversion of 105% for the quarter.
Both cash flow and cash conversion improved compared to the same period last year. So in summary, we are delivering a stable third quarter of 2025. Our underlying business is developing in a solid way, and we can see how our business model with capital, rental, and service is helping us deliver stability, growth, and an underlying earnings trend. In addition to this, we see several important markets showing good signs of increased activity levels and healthy demand for our products and solutions. We see increased sales growth and an overall positive momentum in the business, which makes me believe in a strong finish to 2025 in quarter four.
Next slide please. Our North America business continues to show stable growth this quarter in our largest market, the US. This quarter, we have stable growth, but it is more modest sequentially compared to the last quarter due to the timing of customer deliveries following a very strong previous quarter. We have positive momentum in the US business and an overall high customer activity level, and we expect a stronger quarter. And we also expect sales growth to increase again in quarter four.
Then moving over to Western Europe and the rest of the world that make up the global sales region.
In quarter three, this region grew net sales organically by 5.7%, driven by a strong order book and high customer activity levels. In Western Europe, the organic net sales growth was 2.1% despite the continued weak market development in the United Kingdom. Several other European countries saw good demand and strong organic net sales growth in the quarter, such as France, Germany, Italy, and Spain.
Our service business in Western Europe continued to develop well in the quarter as well. Our business in the rest of the world markets had an organic net sales growth of 15.9% in the quarter, with most markets performing well. Many important markets grew double digits in the quarter, with India standing out with an impressive 40% growth for the second sequential quarter, which now makes India one of the top ten markets for Arjo.
In addition, Australia, Africa, and Singapore all performed well, and we entered into the last quarter of the year with overall good momentum in the rest of the world markets. Next slide please. Our gross margin came in at 41.1% compared to last year's 42.0%. We continue to receive support from lower material costs and price adjustments. These improvements are offset by currency and US tariff headwinds in quarter three. We also had a negative impact from geographic and product mix due to relatively higher sales volumes in global sales. The rest of the world region experienced a high volume of medical beds sales, excluding currency and tariffs. The gross margin would have been on par with last year despite the geo and product mix headwinds. We are, as before, working hard to mitigate the headwinds with continued long-term efficiency gains throughout the value chain, including a solid focus on continuous supply chain efficiencies. We will also continue to work on price adjustments as one part of the puzzle to mitigate the US tariffs and other external cost increases.
Next slide, please. Adjusted EBIT in quarter three was in line with last year, despite headwinds in gross profit, due to increased sales and an improved OpEx to sales ratio. The Ebit margin improved slightly. Excluding the effects of currencies and tariffs, the adjusted Ebit increased over 20%.
On the OpEx side, we have been able to slow down the cost increase compared to quarter two, and our actions to mitigate cost increases are showing effect, which makes organic OpEx development now almost flat compared to last year and gives us an improved OpEx to sales ratio. I'm happy to see the response from the organization with a much sharper focus on cost improvements over the last quarters, and we have now set the tone going forward to manage OpEx in a good way.
We had a negative impact from the revaluation of AP and AR amounting to -4 million SEK in the quarter, which was recorded under other expenses. This was -13 million SEK in the same quarter last year.
Adjusted EBITDA for the quarter was 436 million SEK, versus 434 million SEK in quarter three last year, a result coming from higher sales and improved CapEx to sales ratio. The adjusted EBITDA margin improved by 0.6 percentage points versus last year. Restructuring costs came in at -13 million SEK in the quarter, related to ongoing improvements in the global sales structure to enhance the cost situation for the future. Next slide please. And here I hand over to our CFO Christofer Carlsson.